Ezetimibe, LDL cholesterol and secondary prevention

Perhaps the best and well balanced commentary paper on the recent IMPROVE it study!

http://www.forbes.com/sites/larryhusten/2014/11/17/improve-it-meets-endpoint-and-demonstrates-real-but-modest-clinical-benefit-for-ezetimibe/

http://mobile.nytimes.com/2014/11/18/health/study-finds-alternative-to-statins-in-preventing-heart-attacks-and-strokes.html?referrer